Reg. 32(1) Statement Of Deviation & Variation.
Filed with BSE · · 1 page · English
Transgene Biotek Limited on 6ix
Story so far
Earlier from Transgene Biotek
- Compliance-57 (5): intimation after the end of quarter
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Sep 25 2026
Later from Transgene Biotek
- Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek